Arthur M. Krieg, SVP, R & D, Chief Scien. Officer at Coley Pharmaceutical Group, Inc. (COLY), sold 13,210 shares at $1.89 ($25K) on 2006-10-13, disclosed to the SEC on 2006-10-16.
Open-market sale of $25k COLY by SVP, R & D, Chief Scien. Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CMPI | BUY | 2021-05-19 | $349K | — | Filing → |
| CMPI | BUY | 2021-03-31 | $741K | — | Filing → |
| CMPI | BUY | 2021-03-29 | $290K | — | Filing → |